Results 221 to 230 of about 515,205 (257)
Some of the next articles are maybe not open access.
P-glycoprotein in breast cancer
1989 Resistance to cytotoxic chemotherapy is a major impediment to the successful treatment of breast cancer. Adjuvant chemotherapy, though given under theoretically optimal conditions of low tumor bulk [1], often fails to eradicate micrometastasis.D E, Merkel, S A, Fuqua, W L, McGuireopenaire +2 more sourcesP-Glycoproteins and Multidrug Resistance
Annual Review of Pharmacology and Toxicology, 1996 Multidrug resistance represents a major obstacle in the successful therapy of neoplastic diseases. Studies have demonstrated that this form of drug resistance occurs both in cultured tumor cell lines as well as in human cancers. P-glycoprotein appears to play an important role in such cells by acting as an energy-dependent efflux pump to remove various openaire +2 more sourcesA role of P-glycoprotein in neurology
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2017 On the basis of the analysis of literature data, the authors show a role of P-glycoprotein in the pathogenesis, pharmacotherapy and a prophylaxis of neurologic diseases (Alzheimer's disease, Parkinson's disease, epilepsy, stroke).I V, Chernykh, A V, Shchulkin, E N, Yakusheva, N M, Popova +3 moreopenaire +2 more sourcesCytokine Regulation of P-Glycoprotein
Drug Metabolism Reviews, 2003 P-glycoprotein (Pgp) is a membrane bound transporter involved in the disposition of many endogenous compounds and xenobiotics. Alterations in Pgp expression and activity can significantly affect the disposition of Pgp substrates. Infection and inflammatory stimuli have also been shown to alter drug disposition.Mary Peace, McRae, Kim L R, Brouwer, Angela D M, Kashuba +2 moreopenaire +2 more sourcesThe multidrug resistance P-glycoprotein
Current Opinion in Cell Biology, 1993 P-glycoprotein plays an important role in the resistance of cancers to chemotherapy. Thus, an understanding of the mechanism by which it functions, and its 'normal' physiological role, is of clinical relevance as well as intrinsic interest. Considerable progress towards this goal has been made in the last year or so.openaire +2 more sourcesP-glycoprotein
RCSB Protein Data Bank, 2010 R. Hamish McAllister-Williams, Daniel Bertrand, Hans Rollema, Raymond S. Hurst, Linda P. Spear, Tim C. Kirkham, Thomas Steckler, Delphine Capdevielle, Jean-Philippe Boulenger, Delphine Capdevielle, Jean-Philippe Boulenger, Delphine Capdevielle, Jean-Philippe Boulenger, Cyril Höschl, Martine Cador, Ben J. Harrison, Christos Pantelis, Anthony Riley, Steve Kohut, Alex Hofer, Ben J. Harrison, Christos Pantelis, Seithikurippu R. Pandi-Perumal, D. Warren Spence, Shelby Freedman Harris, Michael J. Thorpy, Milton Kramer, Ian Stolerman, Holden D. Brown, Michael Ragozzino, Klaus A. Miczek, Anne Jackson, Sven Ove Ögren, Oliver Stiedl, Paul R. Pentel, Mark LeSage, Victoria L. Harvey, Tony Dickenson, Christine A. Franco, Marc N. Potenza, Gail Winger, Mei-Chuan Ko, James H. Woods, Matthew I. Palmatier, Rick A. Bevins, Stephan G. Anagnostaras, Jennifer R. Sage, Stephanie A. Carmack, Jos Prickaerts, Jos Prickaerts, Jos Prickaerts, Warren H. Meck, Catalin V. Buhushi, Christoph U. Correll, Ian Stolerman, Mohammed Shoaib, Trevor Robbins, Daniel Hoyer, Thomas Steckler, Linda P. Spear, Luzio Tremolizzo, Gessica Sala, Carlo Ferrarese, Seiya Miyamoto, Thomas Steckler, David S. Tait, Verity J. Brown, Richard A. Depue, Tara L. White, Craig A. Erickson, David J. Posey, Kelly Blankenship, Kimberly A. Stigler, Christopher J. McDougle, Craig A. Erickson, David J. Posey, Kelly Blankenship, Kimberly A. Stigler, Christopher J. McDougle, Ian Stolerman, Jean-Michel Scherrmann, S. Stevens Negus, Dana E. Selley, Laura J. Sim-Selley, Christoph Hiemke, Sophie Tambour, John C. Crabbe, Pierre Baumann, Kim Wolff, Christof Baltes, Thomas Mueggler, Markus Rudin, Alan J. Budney, Robert L. Balster, Sharon Walsh, Robert L. Balster, Sharon Walsh, Robert L. Balster, Sharon Walsh, Andrea Bari, Johannes Mosbacher, Paul Willner, Klaus A. Miczek, Trevor Robbins, Wolfgang Fleischhacker, Etienne Sibille, Nicole Edgar, Sabine M. Hölter, John F. Cryan, Michel Le Moal, Marco Leyton, Sara Tomlinson, Glen Baker, Bernard Le Foll, Naheed (Max) Mirza, Tomasz Schneider, Jos Prickaerts, Jos Prickaerts, Robert L. Balster, Sharon Walsh, Yogita Chudasama, Thomas Steckler, Thomas Steckler, Daniel Hoyer, Stan Floresco, Christine A. Franco, Marc Potenza, Fabrizio Benedetti, Peter Riederer, Siegfried Hoyer, Luzio Tremolizzo, Gessica Sala, Carlo Ferrarese, Luzio Tremolizzo, Gessica Sala, Carlo Ferrarese, Lucio Tremolizzo, Gessica Sala, Carlo Ferrarese, Arthur Christopoulos, Gregory D. Stewart, Patrick M. Sexton, Christoph Hiemke, Malcolm Lader, Stefan Leucht, Mark Slifstein, Linda P. Spear, Samuel G. Siris, Susan Jones, Peter Verheart, Per Svenningsson, Per Andrén, Seithikurippu R. Pandi-Perumal, Milton Kramer, Michael J. Thorpy, Shelby Freedman Harris, D. Warren Spence, John Atack, Hilde Lavreysen, Stephen C. Fowler, Harriet de Wit, Britta Hahn, Stephen C. Fowler, Helen Cassaday, Paul Willner, Darren R. Christensen, Warren K. Bickel, Michael Minzenberg, David Baldwin, C. Neill Epperson, C. Neill Epperson, Lawrence Scahill, I. T. Uzbay, Lisiane Bizarro, Bart Ellenbroek, Linda P. Spear, Patrick D. McGorry, Alison R. Yung, Mark A. Geyer, Johannes Mosbacher, Malcolm Lader, Angela Roberts, Celia Morgan, Valerie Curran, Christine A. Franco, Marc Potenza, Celia Morgan, Valerie Curran, Thomas Steckler, Harriet de Wit, Jill B. Becker, Mary Cain, Michael T. Bardo, Thomas Steckler, Trevor Robbins, Theodora Duka, Sam Hutton, C. Neill Epperson, Celia Morgan, Valerie Curran +199 moreopenaire +2 more sourcesStructure and function of P-glycoprotein
1989 P-glycoprotein remains the best understood molecule that has been implicated in the multidrug resistance phenomenon. As I have attempted to show, our understanding of this molecule is still in its infancy, with many questions as yet unanswered. It is anticipated that the answers to these questions will contribute to our understanding of drug resistance,openaire +2 more sourcesMeasurement of P-glycoprotein Function
2003 The MDR1-encoded P-glycoprotein (Pgp), when overexpressed in tumor cells, confers resistance to many clinically important classes of anticancer drugs. This phenomenon is called multidrug resistance (MDR). The finding that this gene was expressed in many types of human cancers has stimulated many studies into the relevance of this protein for clinical ...openaire +2 more sources
